Bicycle Therapeutics
Price & Volume
Stats
See more52W Range | $4.24-$9.36 |
Market Cap | $317.6M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $72.5M |
Revenue Growth (YoY) | 1,193.3% |
Gross Profit (12 Mos) | -$156.4M |
Diluted EPS | -$3.15 |
News
See moreYahoo Finance • 26 days ago
European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading; Gain 1.3% for Week
Yahoo Finance • last month
Morgan Stanley Updates Bicycle Therapeutics plc (BCYC) Outlook Amid Pipeline Refocus
Yahoo Finance • last month
European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading
Yahoo Finance • 2 months ago
RBC Capital Lowers its Price Target on Bicycle Therapeutics plc (BCYC) to $7 from $11
About
CEO | Dr. Kevin Lee M.B.A., Ph.D. |
Address | Portway Building, Cambridge, United Kingdom, CB21 6GS |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 288 |